Search

everythinglearnresearchcommunity

for

Search:↓

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Inflammation helps stem cells repair tissue by directing their behavior.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

People with acne have more CD4+ immune cells in their skin than healthy people.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

ITK inhibitors may effectively treat alopecia areata.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Autoimmune reactions may cause both alopecia areata and HAM.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

The research found a new way to heal chronic skin ulcers by turning certain cells into skin tissue using specific factors.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.